Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto; Haerani Rasyid; Anastasya Angelica Vicente; Winny Suciangto;

Oxidative stress and inflammation on metabolic abnormalities and renal involvement in prediabetic subjects across Europe Sebastián Mas-Fontao; Esther Civantos; Nisa Boukichou-Abdelkader; Manuel Soto-Catalan; Marta Romeo-Colas; Arantxa Marco; Carmen Gomez-Guerrero; Juan Antonio Moreno; Jaakko Tuomilehto; Rafael Gabriel; Jesús Egido;

Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease Mariana Morais David Pliças; Bernardo Marques da Silva; Edgar Avito Fernandes de Almeida;